The Serum Uric Acid to Serum Creatinine Ratio is an Independent Risk Factor for Diabetic Kidney Disease

References

• Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2016;5(1):49–56.
   PubMedGoogle Scholar
• Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl. 2018;8(1):2–7. doi:10.1016/j.kisu.2017.10.003
   Web of Science ®Google Scholar
• Fioretto P, Pontremoli R. Expanding the therapy options for diabetic kidney disease. Nat Rev Nephrol. 2022;18(2):78–79. doi:10.1038/s41581-021-00522-3
   Web of Science ®Google Scholar
• Donate-Correa J, Ferri CM, Sánchez-Quintana F, et al. Inflammatory Cytokines in Diabetic Kidney Disease: pathophysiologic and Therapeutic Implications. Front Med. 2020;7:628289. doi:10.3389/fmed.2020.628289
   Web of Science ®Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. JAMA. 2016;316(6):602–610. doi:10.1001/jama.2016.10924
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. Addendum. 11. Chronic Kidney Disease and Risk Management: standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl.1):S175–S184. doi:10.2337/dc22-ad08a
   PubMedGoogle Scholar
• Kourtidou C, Stangou M, Marinaki S, Tziomalos K. Novel cardiovascular risk factors in patients with diabetic kidney disease. Int J Mol Sci. 2021;22:20. doi:10.3390/ijms222011196
   Web of Science ®Google Scholar
• Sugahara M, Pak W, Tanaka T, Tang S, Nangaku M. Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Nephrology. 2021;26(6):491–500. doi:10.1111/nep.13860
   PubMed Web of Science ®Google Scholar
• Cheng HT, Xu X, Lim PS, Hung KY. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015. Diabetes Care. 2021;44(1):89–97. doi:10.2337/dc20-1913
   PubMed Web of Science ®Google Scholar
• Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–1523. doi:10.1056/NEJMoa1310799
   PubMed Web of Science ®Google Scholar
• De Cosmo S, Viazzi F, Pacilli A, et al. Serum Uric Acid and Risk of CKD in Type 2 Diabetes. Clin J Am Soc Nephrol. 2015;10(11):1921–1929. doi:10.2215/CJN.03140315
   PubMed Web of Science ®Google Scholar
• Klisic A, Kocic G, Kavaric N, Jovanovic M, Stanisic V, Ninic A. Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2. Clin Exp Med. 2018;18(2):283–290. doi:10.1007/s10238-017-0483-0
   PubMed Web of Science ®Google Scholar
• Guarda NS, Bollick YS, de Carvalho J, Premaor MO, Comim FV, Moresco RN. High Serum Uric Acid Is Associated with Tubular Damage and Kidney Inflammation in Patients with Type 2 Diabetes. Dis Markers. 2019;2019:6025804. doi:10.1155/2019/6025804
   Web of Science ®Google Scholar
• Zhu P, Liu Y, Han L, Xu G, Ran JM. Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies. PLoS One. 2014;9(6):e100801. doi:10.1371/journal.pone.0100801
   PubMed Web of Science ®Google Scholar
• Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122. doi:10.1186/1471-2369-15-122
   PubMed Web of Science ®Google Scholar
• Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239–247. doi:10.1053/j.ajkd.2007.05.013
   PubMed Web of Science ®Google Scholar
• Turgut F, Kasapoğlu B, Kanbay M. Uric acid, cardiovascular mortality, and long-term outcomes in CKD. Am J Kidney Dis. 2009;54(3):582. doi:10.1053/j.ajkd.2009.06.024
   PubMed Web of Science ®Google Scholar
• Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 2016;6:19520. doi:10.1038/srep19520
   PubMed Web of Science ®Google Scholar
• Storhaug HM, Norvik JV, Toft I, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord. 2013;13:115. doi:10.1186/1471-2261-13-115
   PubMed Web of Science ®Google Scholar
• Zalawadiya SK, Veeranna V, Mallikethi-Reddy S, et al. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. Eur J Prev Cardiol. 2015;22(4):513–518. doi:10.1177/2047487313519346
   PubMed Web of Science ®Google Scholar
• Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37(6):1503–1507. doi:10.1161/01.STR.0000221716.55088.d4
   PubMed Web of Science ®Google Scholar
• Ong G, Davis WA, Davis TM. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2010;53(7):1288–1294. doi:10.1007/s00125-010-1735-7
   Web of Science ®Google Scholar
• Palmer TM, Nordestgaard BG, Benn M, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262. doi:10.1136/bmj.f4262
   PubMed Web of Science ®Google Scholar
• Li J, Muraki I, Imano H, et al. Serum uric acid and risk of stroke and its types: the Circulatory Risk in Communities Study (CIRCS). Hypertens Res. 2020;43(4):313–321. doi:10.1038/s41440-019-0385-5
   Web of Science ®Google Scholar
• Al-Daghri NM, Al-Attas OS, Wani K, Sabico S, Alokail MS. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Sci Rep. 2017;7(1):12104. doi:10.1038/s41598-017-12085-0
   PubMed Web of Science ®Google Scholar
• Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diab Vasc Dis Res. 2017;14(3):221–225. doi:10.1177/1479164116680318
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Ninomiya D, Kikuchi A, et al. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons. Diabetes Metab Syndr. 2019;13(3):1851–1856. doi:10.1016/j.dsx.2019.04.023
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Endocrinol Metabo. 2021;37(04):311–398.
   Google Scholar
• Microvascular complications Group, Chinese Diabetes Society. Clinical guideline for the prevention and treatment of diabetic kidney disease in China (2021 edition). Chin J Diabetes Mellitus. 2021;13(8):762–784.
   Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29. doi:10.1056/NEJMoa1114248
   PubMed Web of Science ®Google Scholar
• Chi XH, Li GP, Wang QS, et al. CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations. BMC Nephrol. 2017;18(1):226. doi:10.1186/s12882-017-0637-z
   Web of Science ®Google Scholar
• Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases. 中国高尿酸血症相关疾病诊疗多学科专家共识 [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases]. Zhonghua Nei Ke Za Zhi. 2017;56(3):235–248. Chinese. doi:10.3760/cma.j.issn.0578-1426.2017.03.021
   Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Pradeepa R, Mohan V. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation. Eur J Clin Nutr. 2017;71:7. doi:10.1038/ejcn.2017.40
   Web of Science ®Google Scholar
• Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2017;17(1):76. doi:10.1186/s12902-017-0226-y
   Web of Science ®Google Scholar
• Gao Z, Han F, Yuan X, et al. Analysis of clinical characteristics and risk factors of different types of hyperuricemia in patients with type 2 diabetes. Int J Endocrinol Metab. 2018;38:2.
   Google Scholar
• Wang J, Chen RP, Lei L, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590–598. doi:10.6133/apjcn.2013.22.4.16
   PubMed Web of Science ®Google Scholar
• Mortada I. Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association. Curr Hypertens Rep. 2017;19(9):69. doi:10.1007/s11906-017-0770-x
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. doi:10.1371/journal.pone.0056864
   PubMed Web of Science ®Google Scholar
• Zhou JJ, Chen YQ, Liu Y, et al. Clinical value of serum uric acid/serum creatinine ratio for the degree of tubulointerstitial damage. Beijing Med J. 2012;34(04):253–256.
   Google Scholar
• Yokoyama H, Sone H, Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 2009;24(4):1212–1219. doi:10.1093/ndt/gfn603
   PubMed Web of Science ®Google Scholar
• Thomas MC, Macisaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care. 2009;32(8):1497–1502. doi:10.2337/dc08-2186
   Web of Science ®Google Scholar
• Du RQ, Zhang Y, Li QM, et al. Clinical features of normoalbuminuric diabetic kidney disease in patients with type 2 diabetes. Chin J Diabetes Mellitus. 2017;9(08):494–498.
   Google Scholar
• Buyadaa O, Magliano DJ, Salim A, Koye DN, Shaw JE. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care. 2020;43(1):122–129. doi:10.2337/dc19-1438
   PubMed Web of Science ®Google Scholar
• Wang A, Tian X, Wu S, et al. Metabolic Factors Mediate the Association Between Serum Uric Acid to Serum Creatinine Ratio and Cardiovascular Disease. J Am Heart Assoc. 2021;10(23):e023054. doi:10.1161/JAHA.121.023054
   PubMed Web of Science ®Google Scholar
• Tao J, Shen X, Li J, et al. Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women. Medicine. 2020;99(17):e19959. doi:10.1097/MD.0000000000019959
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Ninomiya D, Akase T, et al. Serum Uric Acid to Creatinine Ratio Independently Predicts Incident Metabolic Syndrome Among Community-Dwelling Persons. Metab Syndr Relat Disord. 2019;17(2):81–89. doi:10.1089/met.2018.0055
   Web of Science ®Google Scholar
• Seo YB, Han AL. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. Metab Syndr Relat Disord. 2021;19(2):70–75. doi:10.1089/met.2020.0086
   Web of Science ®Google Scholar